Page last updated: 2024-08-23

brimonidine tartrate and Hyperemia

brimonidine tartrate has been researched along with Hyperemia in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's2 (22.22)24.3611
2020's4 (44.44)2.80

Authors

AuthorsStudies
Kim, CY; Lee, JS1
Aihara, M; Isobe, T; Kanazawa, M; Koizumi, N; Kojima, S; Minami, H; Suganami, H; Tanihara, H; Yamamoto, T1
Cetinkaya, S; Ucar, F2
Cavet, ME; Ciolino, JB; Gomes, PJ; McLaurin, E1
Aufderheide, A; Avila, MR; Brinton, JP; Durrie, DS; Pasquali, TA; Stahl, ED1
Delgado-Ortega, L; Díaz-Cerezo, S; Pinazo-Durán, MD; Soto-Alvarez, J; Vinuesa-Silva, I; Vinuesa-Silva, JM1
Batoosingh, A; Felix, C; Mundorf, T; Whitcup, S; Williams, R1
Gross, RL; Orengo-Nania, S; Williams, GC1

Reviews

2 review(s) available for brimonidine tartrate and Hyperemia

ArticleYear
Brimonidine tartrate ophthalmic solution 0.025% for redness relief: an overview of safety and efficacy.
    Expert review of clinical pharmacology, 2022, Volume: 15, Issue:8

    Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Erythema; Humans; Hyperemia; Nasal Decongestants; Ophthalmic Solutions; Quality of Life; Quinoxalines; Receptors, Adrenergic

2022
[Development of conjunctival hyperemia with the use of a fixed combination of latanoprost/timolol: systematic review and meta-analysis of clinical trials].
    Archivos de la Sociedad Espanola de Oftalmologia, 2009, Volume: 84, Issue:4

    Topics: Aged; Brimonidine Tartrate; Clinical Trials as Topic; Cloprostenol; Conjunctival Diseases; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Glaucoma; Humans; Hyperemia; Latanoprost; Middle Aged; Ocular Hypertension; Odds Ratio; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Timolol; Travoprost

2009

Trials

4 trial(s) available for brimonidine tartrate and Hyperemia

ArticleYear
Crossover Randomized Study of Pharmacologic Effects of Ripasudil-Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine.
    Advances in therapy, 2023, Volume: 40, Issue:8

    Topics: Adult; Antihypertensive Agents; Brimonidine Tartrate; Endothelial Cells; Glaucoma, Open-Angle; Humans; Hyperemia; Intraocular Pressure; Male; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quinoxalines

2023
Brimonidine Ophthalmic Solution 0.025% for Reduction of Ocular Redness: A Randomized Clinical Trial.
    Optometry and vision science : official publication of the American Academy of Optometry, 2018, Volume: 95, Issue:3

    Topics: Administration, Ophthalmic; Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Brimonidine Tartrate; Conjunctiva; Conjunctival Diseases; Double-Blind Method; Female; Humans; Hyperemia; Male; Middle Aged; Ophthalmic Solutions; Young Adult

2018
Dilute brimonidine to improve patient comfort and subconjunctival hemorrhage after LASIK.
    Journal of refractive surgery (Thorofare, N.J. : 1995), 2013, Volume: 29, Issue:7

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adult; Brimonidine Tartrate; Conjunctival Diseases; Double-Blind Method; Drug Therapy, Combination; Eye Hemorrhage; Female; Histamine H1 Antagonists; Humans; Hyperemia; Keratomileusis, Laser In Situ; Lasers, Excimer; Male; Middle Aged; Naphazoline; Patient Satisfaction; Pheniramine; Postoperative Complications; Prospective Studies; Quinoxalines; Refraction, Ocular; Refractive Surgical Procedures; Visual Acuity; Young Adult

2013
A 3-month comparison of efficacy and safety of brimonidine-purite 0.15% and brimonidine 0.2% in patients with glaucoma or ocular hypertension.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2003, Volume: 19, Issue:1

    Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Conjunctiva; Conjunctivitis, Allergic; Dose-Response Relationship, Drug; Double-Blind Method; Glaucoma; Humans; Hyperemia; Intraocular Pressure; Ocular Hypertension; Quinoxalines; Severity of Illness Index

2003

Other Studies

3 other study(ies) available for brimonidine tartrate and Hyperemia

ArticleYear
The Results of Preoperative Topical Brimonidine Usage in Pterygium Surgery.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2020, Volume: 36, Issue:4

    Topics: Administration, Topical; Adrenergic alpha-2 Receptor Agonists; Adult; Brimonidine Tartrate; Conjunctiva; Female; Hemorrhage; Humans; Hyperemia; Male; Middle Aged; Postoperative Complications; Preoperative Care; Pterygium; Retrospective Studies; Scleritis; Vasoconstriction

2020
The Results of Preoperative Use of Topical Brimonidine in Strabismus Surgery.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2021, Volume: 37, Issue:4

    Topics: Administration, Topical; Adolescent; Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Case-Control Studies; Child; Conjunctival Diseases; Eye Hemorrhage; Female; Hemorrhage; Hemostasis, Surgical; Humans; Hyperemia; Incidence; Intraoperative Complications; Male; Ophthalmic Solutions; Photography; Postoperative Period; Preoperative Care; Retrospective Studies; Strabismus; Young Adult

2021
Incidence of brimonidine allergy in patients previously allergic to apraclonidine.
    Journal of glaucoma, 2000, Volume: 9, Issue:3

    Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Clonidine; Conjunctivitis; Cross Reactions; Dermatitis, Allergic Contact; Drug Hypersensitivity; Female; Glaucoma; Humans; Hyperemia; Incidence; Male; Middle Aged; Quinoxalines; Retrospective Studies; Risk Factors

2000